Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer
Clinical trial NCT03425006 · TERMINATED
Trial details
- NCT number
- NCT03425006
- Sponsor
- University of Pennsylvania
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2021-06-17
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.